Seer, Inc. Class A Common Stock (SEER) Stock
Fundamentals
Recent news

Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.'s Board of Directors
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.'s Board of Directors
SEER

Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
SEER

Seer Q2 Earnings Call Highlights
Seer Q2 Earnings Call Highlights
SEER

SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with SBS Law
SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with SBS Law
SEER
Technicals
Analyst Ratings
Financials
Performance
No data available
Debt & Balance Sheet
No data available
Revenue to Profit
No data available
Earnings
No data available
% positive news of 10 articles
published over the past 14 days
Latest news

Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.'s Board of Directors
Radoff-JEC Group Calls on Meeta Gulyani to Immediately Resign from Seer, Inc.'s Board of Directors
SEER

Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
Radoff-JEC Group Calls on Seer, Inc.'s Board of Directors to Publicly Acknowledge That the Company Needs to Be Taken Private and Disclose Timeline for Evaluating Latest Acquisition Offers
SEER

Seer Q2 Earnings Call Highlights
Seer Q2 Earnings Call Highlights
SEER

SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with SBS Law
SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with SBS Law
SEER

Radoff-JEC Group Submits Further Improved Proposal to Acquire Seer, Inc.
Radoff-JEC Group Submits Further Improved Proposal to Acquire Seer, Inc.
SEER

Radoff-JEC Group Urges Seer Stockholders to Vote “FOR” All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY
Radoff-JEC Group Urges Seer Stockholders to Vote “FOR” All Three of its Independent, Highly Qualified Nominees on the WHITE Proxy Card TODAY
SEER

Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc.
Radoff-JEC Group Announces That Glass Lewis Has Joined ISS in Supporting its Case for Change at Seer, Inc.
SEER

Radoff-JEC Group Announces ISS' Support of its Case for Change at Seer, Inc.
Radoff-JEC Group Announces ISS' Support of its Case for Change at Seer, Inc.
SEER

The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company's Blatant Rewriting of History
The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company's Blatant Rewriting of History
SEER

SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with the Schall Law Firm
SEER Investors Have Opportunity to Join Seer, Inc. Fraud Investigation with the Schall Law Firm
SEER
About Seer, Inc. Class A Common Stock
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Omid C. Farokhzad M.D., Ph.D. | Founder, CEO, & Chair of the Board of Directors | 1969 |
| Mr. David R. Horn | President,Treasurer & CFO | 1968 |
| Kenny Ross | Chief Operations & Product Officer | — |
| Ms. Marissa Dixon | Chief People Officer | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Solvency
Technicals
What the experts say
0 Wall Street Analyst Ratings
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.0 | -7.9 | -11.7 | +36.2 | -12.5 | -1.5 |



